354 related articles for article (PubMed ID: 31067686)
1. The Pathogenesis of Port Wine Stain and Sturge Weber Syndrome: Complex Interactions between Genetic Alterations and Aberrant MAPK and PI3K Activation.
Nguyen V; Hochman M; Mihm MC; Nelson JS; Tan W
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067686
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stain.
Dutkiewicz AS; Ezzedine K; Mazereeuw-Hautier J; Lacour JP; Barbarot S; Vabres P; Miquel J; Balguerie X; Martin L; Boralevi F; Bessou P; Chateil JF; Léauté-Labrèze C;
J Am Acad Dermatol; 2015 Mar; 72(3):473-80. PubMed ID: 25592619
[TBL] [Abstract][Full Text] [Related]
3. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
Shirley MD; Tang H; Gallione CJ; Baugher JD; Frelin LP; Cohen B; North PE; Marchuk DA; Comi AM; Pevsner J
N Engl J Med; 2013 May; 368(21):1971-9. PubMed ID: 23656586
[TBL] [Abstract][Full Text] [Related]
4. A child with Apert syndrome and Sturge-Weber syndrome: could fibronectin or the RAS/MAPK signaling pathway be the connection?
Tan AP; Chong WK
Childs Nerv Syst; 2018 Jun; 34(6):1247-1250. PubMed ID: 29476210
[TBL] [Abstract][Full Text] [Related]
5. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of Sturge-Weber syndrome and large segmental facial port-wine stain.
Li X; Diao P; Liu L; Zhou H; Yang Y; Han C; Jiang X
Dermatol Ther; 2022 May; 35(5):e15404. PubMed ID: 35199900
[TBL] [Abstract][Full Text] [Related]
6. [Sturge-Weber syndrome in port-wine stain patients: a retrospective study on the clinical features and screening strategy].
Wu Y; Yu RJ; Lin XX; Guo WY
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):753-757. PubMed ID: 29050188
[No Abstract] [Full Text] [Related]
7. Sturge-Weber syndrome: from the past to the present.
Sudarsanam A; Ardern-Holmes SL
Eur J Paediatr Neurol; 2014 May; 18(3):257-66. PubMed ID: 24275166
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and Neuroimaging Analysis of 24 Cases of Sturge-Weber Syndrome].
Li YM; Liu C; Cong TX; Zhang HY; Zhou H; Zhao Q; Jiang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):562-566. PubMed ID: 32691568
[TBL] [Abstract][Full Text] [Related]
9. Retrospective review of screening for Sturge-Weber syndrome with brain magnetic resonance imaging and electroencephalography in infants with high-risk port-wine stains.
Zallmann M; Mackay MT; Leventer RJ; Ditchfield M; Bekhor PS; Su JC
Pediatr Dermatol; 2018 Sep; 35(5):575-581. PubMed ID: 30020536
[TBL] [Abstract][Full Text] [Related]
10. Forehead location and large segmental pattern of facial port-wine stains predict risk of Sturge-Weber syndrome.
Boos MD; Bozarth XL; Sidbury R; Cooper AB; Perez F; Chon C; Paras G; Amlie-Lefond C
J Am Acad Dermatol; 2020 Oct; 83(4):1110-1117. PubMed ID: 32413446
[TBL] [Abstract][Full Text] [Related]
11. Sturge-Weber Syndrome: A Review.
Higueros E; Roe E; Granell E; Baselga E
Actas Dermosifiliogr; 2017 Jun; 108(5):407-417. PubMed ID: 28126187
[TBL] [Abstract][Full Text] [Related]
12. The anatomic distribution of isolated and syndrome-associated port-wine stain.
Elias AJ; Hand JL; Tollefson MM; Davis DMR
Pediatr Dermatol; 2021 Jan; 38(1):77-82. PubMed ID: 33170527
[TBL] [Abstract][Full Text] [Related]
13. [Sturge-Weber syndrome].
Maruani A
Presse Med; 2010 Apr; 39(4):482-6. PubMed ID: 20219318
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic association of presence of a somatic GNAQ mutation with port-wine stain distribution in capillary malformation.
Lee KT; Park JE; Eom Y; Lim HS; Ki CS; Lim SY
Head Neck; 2019 Dec; 41(12):4143-4150. PubMed ID: 31532024
[TBL] [Abstract][Full Text] [Related]
15. Sturge-Weber syndrome and dermatomal facial port-wine stains: incidence, association with glaucoma, and pulsed tunable dye laser treatment effectiveness.
Hennedige AA; Quaba AA; Al-Nakib K
Plast Reconstr Surg; 2008 Apr; 121(4):1173-1180. PubMed ID: 18349634
[TBL] [Abstract][Full Text] [Related]
16. Sturge-Weber syndrome in patients with facial port-wine stain.
Piram M; Lorette G; Sirinelli D; Herbreteau D; Giraudeau B; Maruani A
Pediatr Dermatol; 2012; 29(1):32-7. PubMed ID: 21906147
[TBL] [Abstract][Full Text] [Related]
17. Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome.
Sharan S; Swamy B; Taranath DA; Jamieson R; Yu T; Wargon O; Grigg JR
J AAPOS; 2009 Aug; 13(4):374-8. PubMed ID: 19683189
[TBL] [Abstract][Full Text] [Related]
18. The somatic GNAQ mutation c.548G>A (p.R183Q) is consistently found in Sturge-Weber syndrome.
Nakashima M; Miyajima M; Sugano H; Iimura Y; Kato M; Tsurusaki Y; Miyake N; Saitsu H; Arai H; Matsumoto N
J Hum Genet; 2014 Dec; 59(12):691-3. PubMed ID: 25374402
[TBL] [Abstract][Full Text] [Related]
19. New vascular classification of port-wine stains: improving prediction of Sturge-Weber risk.
Waelchli R; Aylett SE; Robinson K; Chong WK; Martinez AE; Kinsler VA
Br J Dermatol; 2014 Oct; 171(4):861-7. PubMed ID: 24976116
[TBL] [Abstract][Full Text] [Related]
20. Skin necrosis due to post-treatment care failure after photodynamic therapy of facial port-wine stain in Sturge-Weber Syndrome - A case report.
Chen Y; Zhang L; Zhang C; Pan L; Wu S
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102546. PubMed ID: 34562646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
